Because mgmt is not skilled in this area and the results are starting to present themselves as unforced errors. For instance, NP stated he wanted to stop the s/c trial for an interim look at 50 patients. Then he said he wanted to release the trial results at the same time.

Someone knowledgeable with clinical trials would NEVER make these types of statements. NP got us here. He deserves credit for that. But he doesn't know what he doesn't know and it's starting to be a real problem in my opinion.